Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Burger

Showing results (261-270 of 342) with videos related to

Pageof 35
Sort By:
Current Oncology (Toronto, Ont.)|November 26, 2024
Modification and Validation of the System Causability Scale Using AI-Based Therapeutic Recommendations for Urological Cancer Patients: A Basis for the Development of a Prospective Comparative StudyEmily Rinderknecht, Dominik von Winning, Anton Kravchuk, et al.
European Urology|January 2, 2008
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyMaximilian Burger, Madelon N M van der Aa, Johanna M M van Oers, et al.
World Journal of Urology|June 15, 2016
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011Matthias May, Hans-Martin Fritsche, Malte W Vetterlein, et al.
BJU International|September 15, 2017
Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre studyMalte W Vetterlein, Philipp Gild, Luis A Kluth, et al.
Journal of Translational Medicine|June 10, 2010
The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trialMaximilian Burger, Nicolas Thiounn, Stefan Denzinger, et al.
BJU International|June 7, 2014
Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patientsIlaria Lucca, Morgan Rouprêt, Luis Kluth, et al.
European Urology|August 2, 2016
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines PanelThomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al.
BJU International|June 25, 2011
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladderMatthias May, Patrick J Bastian, Maximilian Burger, et al.
European Urology|August 16, 2011
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladderPhilipp Nuhn, Matthias May, Maxine Sun, et al.
BJU International|May 8, 2024
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC MonitorMaximilian Haas, Maximilian C Kriegmair, Johannes Breyer, et al.
Pageof 35

Showing results (261-270 of 342) with videos related to

Sort By:
Pageof 35
Current Oncology (Toronto, Ont.)|November 26, 2024
Modification and Validation of the System Causability Scale Using AI-Based Therapeutic Recommendations for Urological Cancer Patients: A Basis for the Development of a Prospective Comparative StudyEmily Rinderknecht, Dominik von Winning, Anton Kravchuk, et al.
European Urology|January 2, 2008
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyMaximilian Burger, Madelon N M van der Aa, Johanna M M van Oers, et al.
World Journal of Urology|June 15, 2016
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011Matthias May, Hans-Martin Fritsche, Malte W Vetterlein, et al.
BJU International|September 15, 2017
Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre studyMalte W Vetterlein, Philipp Gild, Luis A Kluth, et al.
Journal of Translational Medicine|June 10, 2010
The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trialMaximilian Burger, Nicolas Thiounn, Stefan Denzinger, et al.
BJU International|June 7, 2014
Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patientsIlaria Lucca, Morgan Rouprêt, Luis Kluth, et al.
European Urology|August 2, 2016
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines PanelThomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al.
BJU International|June 25, 2011
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladderMatthias May, Patrick J Bastian, Maximilian Burger, et al.
European Urology|August 16, 2011
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladderPhilipp Nuhn, Matthias May, Maxine Sun, et al.
BJU International|May 8, 2024
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC MonitorMaximilian Haas, Maximilian C Kriegmair, Johannes Breyer, et al.
Pageof 35